StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Organic Revenue Growth — Analytical Instruments by Quarter

Organic Revenue Growth — Analytical Instruments (%)

QuarterlyAnnual

Thermo Fisher Scientific Organic Revenue Growth — Analytical Instruments: 6.0% in Q3 2026, up 2.0 pts from a year earlier.

Latest, Q3 2026
6.0%
Period ended Sep 30, 2026
Change on a year earlier
+2.0 pts
4.0% in Q3 2025
History
16 quarters
Since Q3 2022
Sources
4
Documents cited below

Where the Q3 2026 figure comes from

“AI: Organic revenue growth (non-GAAP measure) 3% -4% 4% 0% 0% -2% 7% 6%”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package (Business Segment Information) & SEC MD&A.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOrganic Revenue Growth — Analytical Instruments (%)Year on yearSource
Q3 2026Sep 30, 20266.0%+2.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20267.0%+11.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 2026-2.0%-5.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20250.0%-8.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20254.0%+1.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 2025-4.0%-7.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 20253.0%+4.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20248.0%0.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 20243.0%-5.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 20243.0%-7.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 2024-1.0%-18.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 20238.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 20238.0%-8.0 ptsQ4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 202310.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 202317.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2022Sep 30, 202216.0%–SEC Form 10-Q (10q_2022Q3, filed 2022-11-04) ↗

Breakdown

What makes up organic Revenue Growth — Analytical Instruments

Cite this data

StockData. (2026). Thermo Fisher Scientific Organic Revenue Growth — Analytical Instruments (%), quarterly Q3 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/org-growth-pct-ai

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.